Prucalopride Succinate

Category API

Details	Specifications
CAS Number	179474-85-2
Molecular Formula	C22H32ClN3O7
Molecular Weight	486.0 g/mol.
Synonyms	4-amino-5-chloro-N-[1-(3-methoxypropyl) piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide succinate
Chemical Name	4-amino-5-chloro-N- [1-(3-methoxy propyl) piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide; butane dioic acid
Common name	Prucalopride Succinate
Therapeutic use	Symptomatic treatment of chronic idiopathic constipation.
Background	Prucalopride is a [medication](https://en.wikipedia.org/wiki/Medication) acting as a selective, high affinity [5-HT4 receptor](https://en.wikipedia.org/wiki/5-HT4_receptor) [agonist](https://en.wikipedia.org/wiki/Agonist) which targets the impaired motility associated with chronic [constipation](https://en.wikipedia.org/wiki/Constipation), thus normalizing bowel movements. Prucalopride was approved for medical use in the European Union in 2009, in Canada in 2011, in Israel in 2014, and in the United States in December 2018
Grade	EP & USP
Polymorph	Not applicable
GTI	Risk assessment report available
Nitrosamines	Risk assessment report available
DMF Availability	USDMF# 35038, ASMF: EU / ASMF / 00355
Manufacturing batch size	4.75 Kg
Production capacity	Annual capacity 200 – 250 Kg
Stability data	Available

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Prucalopride Succinate are also Available for

Questions & Answers

FAQ on Prucalopride Succinate

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.